BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9792404)

  • 1. Testing environment for single-gene disorders in U.S. reference laboratories.
    Amos J; Gold B
    Hum Mutat; 1998; 12(5):293-300. PubMed ID: 9792404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commercial molecular diagnostics in the U.S.: The Human Genome Project to the clinical laboratory.
    Amos J; Patnaik M
    Hum Mutat; 2002 Apr; 19(4):324-33. PubMed ID: 11933187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic DHPLC Quality Assurance (DDQA): a collaborative approach to the generation of validated and standardized methods for DHPLC-based mutation screening in clinical genetics laboratories.
    Schollen E; Dequeker E; McQuaid S; Vankeirsbilck B; Michils G; Harvey J; van den Akker E; van Schooten R; Clark Z; Schrooten S; Matthijs G;
    Hum Mutat; 2005 Jun; 25(6):583-92. PubMed ID: 15880509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic testing for patients with renal disease: procedures, pitfalls, and ethical considerations.
    Korf BR
    Semin Nephrol; 1999 Jul; 19(4):319-26. PubMed ID: 10435670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges for clinical genetic DNA testing.
    Trent RJ; Yu B; Caramins M
    Expert Rev Mol Diagn; 2004 Mar; 4(2):201-8. PubMed ID: 14995906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier screening for cystic fibrosis in US genetic testing laboratories: a survey of laboratory directors.
    Kaufman DJ; Katsanis SH; Javitt GH; Murphy JA; Scott JA; Hudson KL
    Clin Genet; 2008 Oct; 74(4):367-73. PubMed ID: 18700896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Traditional and innovative diagnostic tools: when and why they should be applied].
    Cancrini G; Iori A
    Parassitologia; 2004 Jun; 46(1-2):173-6. PubMed ID: 15305711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The link between providers and patients: how laboratories can ensure quality results with genetic testing.
    Quillin JM; Jackson-Cook C; Bodurtha J
    Clin Leadersh Manag Rev; 2003; 17(6):351-7. PubMed ID: 14692080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The centralized prenatal genetics screening program of New York City: I. Developmental phase.
    Hsu LY
    Am J Med Genet; 1981; 8(3):321-30. PubMed ID: 7234902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the geneticist in testing and counseling for inherited thrombophilia.
    Reich LM; Bower M; Key NS
    Genet Med; 2003; 5(3):133-43. PubMed ID: 12792420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic testing: considerations for pediatric nephrologists.
    Guay-Woodford LM; Knoers NV
    Semin Nephrol; 2009 Jul; 29(4):338-48. PubMed ID: 19615555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of molecular genetics technology for prenatal diagnosis of genetic disease.
    Ward PA
    Clin Lab Sci; 1991; 4(5):287-90. PubMed ID: 10149419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic kits in parasitology: which controls?].
    Rossi P
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External quality assurance of DNA testing for thrombophilia mutations.
    Hertzberg M; Neville S; Favaloro E; McDonald D
    Am J Clin Pathol; 2005 Feb; 123(2):189-93. PubMed ID: 15842041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience and outcome of 3 years of a European EQA scheme for genetic testing of the spinocerebellar ataxias.
    Seneca S; Morris MA; Patton S; Elles R; Sequeiros J
    Eur J Hum Genet; 2008 Aug; 16(8):913-20. PubMed ID: 18301445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic services in the United States.
    Chen H; Wertelecki W
    Jpn J Hum Genet; 1994 Jun; 39(2):275-88. PubMed ID: 8086646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.